Brought to you by:
SVS PAD course postponed
The new Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Skills Course has been postponed amid the COVID-19 pandemic recent surge in cases, the Society has announced. The course—which had been set to run Feb. 11–12—will now take place…
Smoking status ‘should not deter nor delay’ endovascular intervention in femoropopliteal vessels
Smoking does not seem to affect reocclusion rates, interval to reintervention and the total number of interventions in peripheral arterial disease (PAD) patients with stents in the femoropopliteal segment, new research showed. These were among the findings delivered by Sascha…
Learn by doing at February SVS PAD workshop
The Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Workshop in February will feature four hours of hands-on surgical skills training, on 10 different facets of PAD treatment. “We are offering the chance for surgeons to be trained by…
Rise in cardiovascular disease, vascular surgeon burnout presents a public health crisis, Western Vascular Society hears
Cases of cardiovascular disease are rising across the U.S., with large disparities seen in ethnic groups and poorer geographical areas. In combination with increased burnout in the vascular workforce, this has led to a public health crisis that requires immediate…
Endologix announces completion of enrollment in TORUS 2 study for PAD in SFA
Endologix has completed enrollment in the TORUS 2 investigational device exemption (IDE) clinical study in the U.S., a press release reports. The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the Torus stent…
Prediabetes screening: ‘Target of reducing disparities should be geared towards advocacy’
On Aug. 24, the United States Preventive Services Task Force (USPSTF) published the newly updated recommendations regarding screening for prediabetes and type-2 diabetes mellitus.1,2 The recommendation has been graded B, which translates to at least fair evidence to suggest that…
First patient enrolled in Disrupt BTK II study for long, calcified, below-the-knee lesions
Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the Shockwave peripheral intravascular lithotripsy (IVL) system for the treatment of calcified peripheral lesions below the knee (BTK), including some…
Take advantage of SVS diabetes resources
November is National Diabetes Month. The Society for Vascular Surgery (SVS) has many resources to help its members educate their patients and families and reach out to referring podiatrists and other providers. Members can customize many of the resources with…
Hispanic adults with PAD access inpatient care most often via the emergency room
Hispanic adults hospitalized for treatment of symptoms of peripheral arterial disease (PAD) were more likely to access this care by going to the emergency room (ER), and they experienced longer and more expensive hospitalizations than non-Hispanic white patients with PAD,…
Philips announces large-scale study outcomes on use of IVUS in peripheral interventions
Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health outcomes of peripheral vascular interventions guided by intravascular ultrasound (IVUS). The study was conducted independently by…